ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 61 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $3,428,441 | -41.6% | 4,554,252 | +16.3% | 2.60% | -51.8% |
| Q3 2023 | $5,872,500 | -28.4% | 3,915,000 | -24.1% | 5.39% | -26.9% |
| Q2 2023 | $8,199,915 | +61.7% | 5,157,179 | -27.0% | 7.38% | +68.3% |
| Q1 2023 | $5,069,994 | +23.8% | 7,067,179 | 0.0% | 4.38% | +12.0% |
| Q4 2022 | $4,095,430 | – | 7,067,179 | – | 3.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 919,000 | $4,816,000 | 2.29% |
| RTW INVESTMENTS, LP | 6,256,840 | $32,786,000 | 2.24% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $2,515,000 | 1.08% |
| Bpifrance SA | 828,262 | $4,340,000 | 0.49% |
| WS MANAGEMENT LLLP | 888,722 | $4,657,000 | 0.28% |
| Eventide Asset Management | 1,146,580 | $6,008,000 | 0.21% |
| 683 Capital Management, LLC | 362,386 | $1,899,000 | 0.17% |
| Orbimed Advisors | 1,243,200 | $6,514,000 | 0.10% |
| Sofinnova Investments, Inc. | 159,237 | $835,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 119,673 | $627,000 | 0.07% |